IDSA- NOT Recommended

Infectious Diseases Society of America 
(IDSA)

NOT RECOMMENDED 
AS A SOURCE OF ACCURATE INFORMATION

Quote from the Attorney General's Office

"The IDSA's 2006 Lyme disease guideline panel undercut its credibility by allowing individuals with financial interests -- in drug companies, Lyme disease diagnostic tests, patents and consulting arrangements with insurance companies -- to exclude divergent medical evidence and opinion.”


More Quotes from the Attorney General

May 1, 2008

Attorney General Richard Blumenthal today announced that his antitrust investigation has uncovered serious flaws in the Infectious Diseases Society of America's (IDSA) process for writing its 2006 Lyme disease guidelines…

The IDSA guidelines have sweeping and significant impacts on Lyme disease medical care. They are commonly applied by insurance companies in restricting coverage for long-term antibiotic treatment or other medical care and also strongly influence physician treatment decisions.

Insurance companies have denied coverage for long-term antibiotic treatment relying on these guidelines as justification. The guidelines are also widely cited for conclusions that chronic Lyme disease is nonexistent. My office uncovered undisclosed financial interests held by several of the most powerful IDSA panelists.”

Read full press release here.


Articles and Additional Information